Deseret Labs

Deseret Laboratories is a privately held, revenue-generating contract manufacturer serving the dermatology and drug delivery sectors, among other consumer health markets. The company leverages a broad suite of manufacturing technologies, including granulation, tableting, and molecular processing, within a 130,000-square-foot facility to offer end-to-end production services. With a long operational history and a focus on quality and customer partnership, DLI occupies a stable niche in the CDMO landscape, though it faces risks from client concentration and intense industry competition. Its outlook is tied to the growth of the nutraceutical and generic OTC pharmaceutical markets.

Integrated contract manufacturing platform for solid and semi-solid dosage forms, including granulation, tableting, coating, encapsulation, molecular processing, and packaging services.

DLI competes in the fragmented CDMO market, facing competition from large multinational firms (e.g., Lonza, Catalent) and smaller niche specialists. Its primary competitive differentiation is its full-service, integrated U.S. facility, customer-centric approach, and expertise in solid dose forms for nutraceuticals and dermatology.